MCCANN COREY (President and CEO) exercised options at PEAR THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/18/2023ACC: 0001062993-23-001039
DirectorOfficer· President and CEO
Since Dec 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
88K acquired · 88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+88K
Price / share
—
Trade value
—
% of position
1.1%
1/14/2023
8.16M→8.25M
Total
Net shares
+88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2023 | M · Option Exercise | +88K | — | — | 1.1% | 8.16M | 8.25M |
| Total | +88K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
88K shares
Shares
−88K
Strike price
Held after
178.67K
Exercisable
—
1/14/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock88K shares | 1/14/2023 | M · Option Exercise | −88K | — | 178.67K |
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned1.69M
Class A Common Stock
IndirectShares owned986.52K
Total
2.67M indirect2.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 1.69M | Indirect |
| Class A Common Stock | 986.52K | Indirect |
| Total | 2.67M | 2.67M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported